Amphastar Pharmaceuticals (AMPH): Buy, Sell, or Hold Post Q4 Earnings? [Yahoo! Finance]
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: Yahoo! Finance
This was partly driven by its softer quarterly results and might have investors contemplating their next move. Is now the time to buy Amphastar Pharmaceuticals, or should you be careful about including it in your portfolio? Check out our in-depth research report to see what our analysts have to say, it's free Why Is Amphastar Pharmaceuticals Not Exciting? Even with the cheaper entry price, we're cautious about Amphastar Pharmaceuticals. Here are three reasons there are better opportunities than AMPH and a stock we'd rather own. 1. Lackluster Revenue Growth Long-term growth is the most important, but within healthcare, a stretched historical view may miss new innovations or demand cycles. Amphastar Pharmaceuticals's recent performance shows its demand has slowed as its annualized revenue growth of 5.4% over the last two years was below its five-year trend. We're wary when companies in the sector see decelerations in revenue growth, as it could signal changing consumer tastes
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- Why Amphastar Pharmaceuticals (AMPH) Shares Are Sliding Today [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals (AMPH) had its "hold" rating reaffirmed by Jefferies Financial Group Inc.. They now have a $22.00 price target on the stock.MarketBeat
- Amphastar Pharmaceuticals Highlights Baqsimi Milestones, Primatene Growth at Needham Conference [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals (AMPH) was downgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "hold (c-)" to "sell (d+)".MarketBeat
- Amphastar Pharmaceuticals (AMPH) had its price target lowered by Barclays PLC from $30.00 to $23.00. They now have an "equal weight" rating on the stock.MarketBeat
AMPH
Earnings
- 2/26/26 - Miss
AMPH
Sec Filings
- 4/13/26 - Form ARS
- 4/13/26 - Form DEFA14A
- 4/13/26 - Form DEF
- AMPH's page on the SEC website